Glaucoma is a chronic condition that causes damage to the eye’s optic nerve and progressively gets worse. The damage occurs though a buildup of pressure inside the eye and normally doesn’t show up till later on in life. The pressure is called intraocular pressure can damage the optic nerve and cause permanent loss of vision within a few years.
It has been discovered that Delta 9 – THC in the form of a topical application as in eye drops have been far less more effective than smoked cannabinoids. During a recent discovery of cannabinoid receptors located in the ocular area which has stimulated new research in the development of a topical eye drop form which would minimize the psychological effects of cannabis sativa.
Cannabinoids have been shown to decrease intraocular pressure for brief periods of time with consistent use of cannabinoids in smoking, vaporizing and ingesting cannabinoid oil form. Some of the new delivery methods are extended release oral capsules where there is improved cannabinoids that work with other medications or cannabinoids other than THC such as cannabidiol (CBD).